Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
doi: 10.3390/cancers13164233
Redemplo (plozasiran): Plozasiran, an RNA interference therapeutic, reduces apoC-III production, impacting triglyceride metabolism in familial chylomicronemia syndrome (FCS) patients
Such an approach illustrates the utility of HDX-MS for mapping PPIs and its potential for elucidating the interactions between excipients and proteins, which would have direct applicability to developability considerations and formulation composition design
Because the peptide remains highly stable in gastric environments, it has become a preferred compound for researchers examining gut-related biological processes and tissue recovery mechanisms
US$ 20.35
US$ 26.04
US$ 20.85
US$ 23.99
US$ 4229.88
Sold : Login>>